Analyte Index
INTRODUCTION
“Fixed” grading limits use either a constant concentration (type C limits) or a constant percentage of the target value (type P limits) to define a range of acceptable performance above and below the target value.
The target value for qualitative or semi-quantitative results is the most frequently reported (consensus) value(s) of all valid results.
The target value for quantitative results is the mean of all results after removal of outliers. In contrast to fixed limits, limits based on standard deviations (SDs) can lead to different grading ranges for the same analyte, even when different peer groups have the same means.
The limits required by CMS consist of all three types discussed above; fixed concentration (type C), fixed percentage (type P), and 3SD (type S):
All three types of CMS grading limits are used. Not all analytes listed have CMS limits.
Proficiency testing is not required by CMS or other agencies for analytes/procedures which have no CMS-mandated grading limits. Such analytes/procedures are identified in the Analytes Index as well as on the reporting forms.
Results for these CMS-unscored analytes are not included in computing participants’ overall CMS subspecialty scores. Therefore these scores do not appear on CMS Cumulative Summary reports; they appear only on graded reports (which do not go to CMS).
In the interest of uniformity, the limits used for CMS-unscored analytes are derived from those used for CMS-scored analytes which are similar.
A listing of the limits used for all analytes/procedures, both CMS-scored (regulated analytes) and CMS-unscored, follows.
CMS and CDC have proposed the inclusion of new analytes as regulated. Where the new proposed ranges differ from our historic ranges, we have adopted the new proposed ranges so laboratories will be prepared for analyte regulation if or when it occurs.
CMS Regulated |
CAP Accepted |
Program Analyte |
SD |
Grading Limits Concentration |
% |
||
NR |
NR = CAP acceptance not required |
||||||
|
|
|
|
|
|||
|
|
|
|
||||
|
NR |
Creatinine, Urine |
|
3 mg/dL |
15 |
||
|
NR |
Nitrite, Urine |
|
pos/neg, +/- 1 pad |
|
||
|
NR |
pH, Urine |
|
0.5 (+/- 1pad) |
|
||
|
NR |
Specific Gravity, Urine |
|
0.01 |
|
||
NR |
Interpretation |
correct/incorrect |
|||||
|
|
|
|
||||
|
Acetone |
|
pos/neg, +/- 1 pad |
|
|||
CMS |
Alcohol (Ethanol) |
|
|
25 |
|||
|
Beta Hydroxybutyrate (qualitative) |
|
0.1 mmol/L |
20 |
|||
|
|
|
|||||
|
Ammonia, Serum |
|
10 umol/L |
10 |
|||
|
|
|
|||||
|
Bilirubin, Direct |
|
0.4 mg/dL |
20 |
|||
|
Bilirubin, Neonatal |
|
0.4 mg/dL |
20 |
|||
|
Bilirubin, Total |
|
0.4 mg/dL |
20 |
|||
|
|
|
|||||
|
Bilirubin, Direct |
|
0.4 mg/dL |
20 |
|||
|
Bilirubin, Neonatal |
|
0.4 mg/dL |
20 |
|||
CMS |
Bilirubin, Total |
|
0.4 mg/dL |
20 |
|||
|
|
|
|||||
|
Calcium, Ionized |
|
0.25 mmol/L |
|
|||
Chloride |
|
|
5 |
||||
Glucose |
|
6 mg/dL |
10 |
||||
|
Lactate (Lactic Acid), Whole Blood |
|
2 mg/dL |
25 |
|||
CMS |
pCO2 |
|
5.0 mm Hg |
8 |
|||
CMS |
pH, Blood Gas |
|
0.04 |
|
|||
CMS |
pO2 |
3SD |
|
|
|||
Potassium |
|
0.5 mmol/L |
|
||||
Sodium |
|
4 mmol/L |
|
||||
|
|
|
|||||
|
BNP |
3SD |
20 pg/mL |
|
|||
CMS |
CK-2/CKMB |
3SD |
|
|
|||
|
Myoglobin, Quantitative |
|
15 ng/mL |
30 |
|||
|
NT-proBNP |
3SD |
20 pg/mL |
|
|||
|
Troponin I |
|
0.9 ng/mL |
25 |
|||
HS Troponin I |
0.9 ng/mL |
25 |
|||||
|
Troponin T |
|
0.2 ng/mL |
30 |
|||
|
|
|
|||||
|
BNP |
3SD |
20 pg/mL |
|
|||
|
Myoglobin, Quantitative |
|
15 ng/mL |
30 |
|||
|
NT-proBNP |
3SD |
20 pg/mL |
|
|||
|
Troponin I |
|
0.9 ng/mL |
25 |
|||
|
Troponin T |
|
0.2 ng/mL |
30 |
|||
|
|
|
|||||
CMS |
Albumin |
|
|
10 |
|||
CMS |
Alkaline Phosphatase |
|
|
30 |
|||
CMS |
ALT/SGPT |
|
|
20 |
|||
CMS |
AST/SGOT |
|
|
20 |
|||
|
Bicarbonate (CO2) |
|
4 mEq/L |
20 |
|||
CMS |
Bilirubin, Total |
|
0.4 mg/dL |
20 |
|||
CMS |
Calcium |
|
1.0 mg/dL |
|
|||
CMS |
Chloride |
|
|
5 |
|||
CMS |
Cholesterol, Total |
|
|
10 |
|||
CMS |
Creatinine |
|
0.3 mg/dL |
15 |
|||
CMS |
Glucose |
|
6 mg/dL |
10 |
|||
|
Phosphorus |
|
0.3 mg/dL |
15 |
|||
CMS |
Potassium |
|
0.5 mmol/L |
|
|||
CMS |
CAP |
Pregnancy, Serum Qualitative |
|
pos/neg |
|
||
CMS |
Protein, Total |
|
|
10 |
|||
CMS |
Sodium |
|
4 mmol/L |
|
|||
CMS |
Triglycerides |
|
|
25 |
|||
CMS |
Urea Nitrogen, Blood |
|
2 mg/dL |
9 |
|||
CMS |
Uric Acid |
|
|
17 |
|||
|
|
|
|||||
CMS |
Alpha-fetoprotein (AFP) |
3SD |
|
|
|||
CMS |
Amylase, Serum/Plasma |
|
|
30 |
|||
Bilirubin, Direct |
0.4 mg/dL |
20 |
|||||
CMS |
Cortisol |
|
|
25 |
|||
CMS |
Cholesterol (HDL) |
30 |
|||||
CMS |
Creatine Kinase, Total (CK or CPK) |
|
|
30 |
|||
Fructosamine, DMF |
0.45 mmol/L |
30 |
|||||
Fructosamine, Polylysine |
45 mml./L |
30 |
|||||
Gamma-Glutamyl Transferase (GGT) |
5 IU/L |
15 |
|||||
CMS |
CAP |
hCG Test, Serum Quantitative |
3SD |
|
|
||
CMS |
Iron |
|
|
20 |
|||
CMS |
Lactate Dehydrogenase, Total (LD/LDH) |
20 |
|||||
|
Lactic Acid, Serum |
|
0.3 mmol/L |
25 |
|||
|
Lipase |
|
|
30 |
|||
CMS |
Magnesium, mg/dL |
|
|
25 |
|||
CMS |
Magnesium, mEq/L |
|
|
25 |
|||
CMS |
T Uptake |
3SD |
|
|
|||
CMS |
T3 (Triiodothyronine), Total |
3SD |
|
|
|||
CMS |
T4 (Thyroxin), Free |
3SD |
|
|
|||
CMS |
T4 (Thyroxin), Total |
|
1.0 ugdL |
20 |
|||
CMS |
Thyroid Stimulating Hormone (TSH) |
3SD |
|
|
|||
Transferrin |
10 mg/dl |
7 |
|||||
TIBC (Total Iron Binding Capacity) |
20 |
||||||
UIBC (UnsaturatedIBC) |
20 |
||||||
|
|
|
|||||
|
Bicarbonate (CO2) |
|
4 mEq/L |
20 |
|||
|
Calcium, Ionized |
|
0.25 mmol/L |
|
|||
CMS |
Chloride |
|
|
5 |
|||
CMS |
Creatinine |
|
0.3 mg/dL |
15 |
|||
CMS |
Glucose |
|
6 mg/dL |
10 |
|||
CMS |
Hematocrit |
|
|
6 |
|||
CMS |
Hemoglobin |
|
|
7 |
|||
|
Lactate (Lactic Acid), Whole Blood |
|
2 mg/dL |
25 |
|||
Magnesium, Ionized |
25 |
||||||
CMS |
pCO2 |
|
5.0 mm Hg |
8 |
|||
CMS |
pH, Blood Gas |
|
0.04 |
|
|||
CMS |
pO2 |
3SD |
|
|
|||
CMS |
Potassium |
|
0.5 mmol/L |
|
|||
CMS |
Sodium |
|
4 mmol/L |
|
|||
CMS |
Urea Nitrogen, Blood |
|
2 mg/dL |
9 |
|||
|
|
|
|||||
|
Ferritin |
|
4.5 ng/mL |
20 |
|||
|
Folate |
|
1.0 ng/mL |
30 |
|||
|
Homocysteine |
|
2.5 umol/L |
20 |
|||
|
Pre-albumin |
|
|
25 |
|||
|
Prolactin |
|
3.6 ng/mL |
20 |
|||
|
Prostate-specific Antigen (PSA), Total |
|
0.2 ng/mL |
20 |
|||
|
T3 (Triiodothyronine), Free |
|
0.3 ng/mL |
30 |
|||
|
Testosterone,Total |
|
0.2 ng/mL |
30 |
|||
|
Vitamin B12 |
|
60 pg/mL |
25 |
|||
|
|
|
|||||
Albumin, Fluids |
10 |
||||||
|
Amylase, Urine/Fluids |
|
|
30 |
|||
|
Calcium, Urine |
|
1.0 mg/dL |
|
|||
|
Chloride, Urine/Fluids |
|
|
5 |
|||
Cholesterol, Fluids |
10 |
||||||
|
Creatinine, Fluids |
|
3 mg/dL |
15 |
|||
|
Glucose, Urine/Fluids |
|
6 mg/dL |
10 |
|||
Lactic Acid, Fluids |
0.3 mmol/L |
25 |
|||||
Lactate Dehydrogenase (LD or LDH), Fluids |
20 |
||||||
|
Magnesium, Urine |
|
|
25 |
|||
|
Osmolality, Urine |
|
9 mOsm/kg |
10 |
|||
pH, Fluids |
0.5 |
||||||
|
Phosphorus, Urine |
|
3mg/dL |
15 |
|||
|
Potassium, Urine |
|
3mmol/L |
15 |
|||
|
Protein, Total, Urine/Fluids |
|
1 mg/L |
25 |
|||
|
Sodium, Urine/Fluids |
|
4 mmol/L |
4 |
|||
Triglycerides, Fluids |
25 |
||||||
|
Urea Nitrogen, Urine |
|
|
9 |
|||
|
Uric Acid, Urine/Fluids |
|
0.3 mg/dL |
17 |
|||
|
|
|
|
||||
|
|
Albumin |
|
|
10 |
||
|
|
Alkaline Phosphatase |
|
|
30 |
||
|
|
ALT/SGPT |
|
|
20 |
||
|
|
AST/SGOT |
|
|
20 |
||
|
|
Bicarbonate (CO2) |
|
4 mEq/L |
20 |
||
|
|
Bilirubin, Total |
|
0.4 mg/dL |
20 |
||
|
|
Calcium |
|
1.0 mg/dL |
|
||
|
|
Chloride |
|
|
5 |
||
|
Cholesterol, HDL |
|
|
30 |
|||
|
Cholesterol, Total |
|
10 |
||||
|
|
Creatine Kinase, Total (CK or CPK) |
|
|
30 |
||
|
|
Creatinine |
|
0.3 mg/dL |
15 |
||
|
|
Gamma-Glutamyl Transferase (GGT) |
|
5 IU/L |
15 |
||
|
Glucose |
|
6 mg/dL |
10 |
|||
Phosphorus |
0.3 mg/dL |
10 |
|||||
|
|
Potassium |
|
0.5 mmol/L |
|
||
|
|
Protein, Total |
|
|
10 |
||
|
|
Sodium |
|
4 mmol/L |
|
||
|
|
Triglycerides |
|
|
25 |
||
|
|
Urea Nitrogen, Blood |
|
2 mg/dL |
9 |
||
|
|
Uric Acid |
|
|
17 |
||
|
|
|
|
||||
|
C-Reactive Protein, high sensitivity (hsCRP) |
1mg/dL |
30 |
||||
|
|
|
|
||||
|
NR |
D-Dimer, Qual |
|
pos/neg |
|
||
|
D-Dimer, Quant, ng/mL |
2SD |
30 ng/mL |
|
|||
|
D-Dimer, Quant, ugFEU/mL |
2SD |
0.3 ugFEU/mL |
|
|||
|
|
|
|||||
|
Acetaminophen |
|
2.5 mg/mL |
25 |
|||
CMS |
Carbamazepine |
|
|
25 |
|||
CMS |
Digoxin |
|
2.0 ng/mL |
15 |
|||
CMS |
Gentamicin |
|
|
25 |
|||
CMS |
Lithium |
|
0.3 mmol/L |
20 |
|||
CMS |
Phenobarbital |
|
|
20 |
|||
CMS |
Phenytoin |
|
|
25 |
|||
|
Salicylates-mg/dL |
|
0.2 mg/dL |
25 |
|||
CMS |
Theophylline |
|
|
25 |
|||
CMS |
Tobramycin |
|
|
25 |
|||
CMS |
Valproic Acid |
|
|
25 |
|||
|
Vancomycin |
|
1.5 ug/mL |
25 |
|||
|
|
|
|||||
|
Acetaminophen |
|
pos/neg |
|
|||
|
Alcohol (Ethanol) |
|
pos/neg |
|
|||
Amphetamines |
|
pos/neg |
|||||
|
Amphetamines |
|
pos/neg |
|
|||
|
Barbiturates |
|
pos/neg |
|
|||
|
Benzodiazepines |
|
pos/neg |
|
|||
|
Buprenorphine |
|
pos/neg |
|
|||
|
Cannabinoids / Marijuana |
|
pos/neg |
|
|||
|
Cocaine Metabolites |
|
pos/neg |
|
|||
|
Cotinine |
|
pos/neg |
|
|||
|
Ecstasy (MDMA) |
|
pos/neg |
|
|||
Fentanyl |
pos/neg |
||||||
|
LSD (Lysergic Acid Diethylamide) |
|
pos/neg |
|
|||
K2 Metabolite (UR-144) (JWH-073) |
pos/neg |
||||||
K3 Pinaca |
pos/neg |
||||||
|
MDMA (Ecstasy) |
|
pos/neg |
|
|||
|
Methadone |
|
pos/neg |
|
|||
|
Methadone Metabolite |
|
pos/neg |
|
|||
|
Methamphetamine |
|
pos/neg |
|
|||
|
Methaqualone |
|
pos/neg |
|
|||
|
Opiates |
|
pos/neg |
|
|||
|
Oxycodone |
|
pos/neg |
|
|||
|
Phencyclidine (PCP) |
|
pos/neg |
|
|||
|
Propoxyphene |
|
pos/neg |
|
|||
Tramadol |
pos/neg |
||||||
|
Tricyclic Antidepressants (TCA) |
|
pos/neg |
|
|||
Zolpidem |
pos/neg |
||||||
|
|
|
|
||||
|
CAP |
DHEA-S |
|
6.0 ug/dL |
15 |
||
|
CAP |
Estradiol |
|
3 pg/mL |
30 |
||
|
|
Estriol (unconjugated) |
|
3.0 ng/mL |
25 |
||
|
CAP |
Follicle Stimulating Hormone (FSH) |
|
2 mIU/mL |
18 |
||
|
CAP |
Luteinizing Hormone (LH) |
|
2 mIU/mL |
20 |
||
|
CAP |
Progesterone |
|
0.3 ng/mL |
|||
|
|
||||||
|
NR |
Fructosamine, DMF |
|
0.45 mmol/L |
30 |
||
|
NR |
Fructosamine, Polylysine |
|
45 mmol/L |
30 |
||
|
|
|
|
||||
|
|
Glucose |
|
6 mg/dL |
10 |
||
|
|
Hemoglobin |
|
|
7 |
||
|
|
|
|
||||
|
|
Glycohemoglobin, 2 vial |
|
1 percentage unit |
15 |
||
|
Glycohemoglobin, 5 vial |
|
1 percentage unit |
15 |
|||
|
|
|
|||||
|
Hemoglobin A1c, Afinion (HbA1c) |
|
1 percentage unit |
15 |
|||
|
|
|
|||||
|
C-Peptide |
|
1.0 ng/mL |
30 |
|||
|
Insulin |
|
1.5 uIU/mL |
30 |
|||
|
PTH (Parathyroid Hormone) |
|
0.9 ng/mL |
25 |
|||
|
Vitamin D |
3SD |
2 ng/mL |
|
|||
|
|
|
|||||
|
Iron, Binding Capacity, Total (TIBC) |
|
|
25 |
|||
|
Iron, Binding Capacity, Unsaturated (UIBC) |
|
|
25 |
|||
|
Transferrin |
|
10 mg/dL |
7 |
|||
Fecal Lactoferrin |
pos/neg |
||||||
|
|
|
|||||
|
Lead, Blood |
|
4ug/dL |
10 |
|||
|
|
|
|||||
|
Apolipoproteins, A1 |
|
25 mg/dL |
30 |
|||
|
Apolipoproteins, B |
|
20 mg/dL |
25 |
|||
CMS |
Cholesterol, HDL |
|
|
30 |
|||
|
Cholesterol, LDL (Direct) |
|
15 mg/dL |
20 |
|||
|
Lipoprotein (a) |
|
10 mg/dL |
30 |
|||
|
|
|
|||||
|
Creatinine, Urine |
|
3 mg/dL |
15 |
|||
|
Creatinine, Urine, Semiquantitative |
|
pos/neg |
|
|||
|
Microalbumin, Quantitative |
|
10 mg/L |
25 |
|||
|
Microalbumin, Semiquantitative & qualitative |
|
pos/neg |
|
|||
|
|
|
|
||||
|
NR |
Occult Blood, Fecal (FOB) |
|
pos/neg |
|
||
|
|
|
|
||||
|
NR |
Occult Blood, Gastric |
|
pos/neg |
|
||
NR |
Occult Blood,pH |
|
pos/neg |
||||
|
|
|
|
||||
|
|
Carboxyhemoglobin |
|
3 percentage units |
25 |
||
|
Hemoglobin |
|
|
7 |
|||
|
|
Methemoglobin |
|
2 percentage units |
10 |
||
|
|
Oxyhemoglobin |
|
3 percentage units |
7 |
||
p2PSA |
0.9 ng/mL |
30 |
|||||
CMS |
Pregnancy, Serum |
|
pos/neg |
|
|||
CMS |
CAP |
Pregnancy, Urine |
|
pos/neg |
|
||
CAP |
Pregnancy, Urine |
pos/neg |
|||||
|
|
|
|
||||
|
|
Sex Hormone Binding Globulin (SHBG) |
3SD |
10 nmol/L |
|
||
|
|
Testosterone, Bioavailable |
|
0.3 ng/mL |
30 |
||
|
|
Testosterone, Free |
|
0.3 ng/mL |
30 |
||
Testosterone, Total |
|
0.3 ng/mL |
30 |
||||
|
|
|
|
||||
|
|
Beta-2-microglobulin |
|
0.06 mg/L |
30 |
||
|
CA 125 |
|
9 U/mL |
20 |
|||
|
CA 15-3 |
2SD |
2 IU/mL |
|
|||
|
CA 19-9 |
2SD |
1.5 IU/mL |
|
|||
|
CA 27.29 |
2SD |
3 IU/mL |
|
|||
|
Carcinoembryonic Antigen (CEA) |
|
1.2 ng/mL |
30 |
|||
|
Prostate-specific Antigen (PSA), Free |
|
0.9 ng/mL |
30 |
|||
|
Prostatic Acid Phosphatase (PAP) |
|
1.2 ng/mL |
30 |
|||
|
Thyroglobulin |
3SD |
1 ng/mL |
|
|||
|
Thyroglobulin Antibody |
2SD |
2 IU/mL |
|
|||
|
|
|
|||||
|
Bilirubin, Urine |
|
pos/neg, +/- 1 pad |
|
|||
|
Creatinine, Urine |
|
pos/neg, +/- 1 pad |
|
|||
|
Glucose, Urine |
|
pos/neg, +/- 1 pad |
|
|||
|
Hemoglobin/Blood, Urine |
|
pos/neg, +/- 1 pad |
|
|||
|
Ketones |
|
pos/neg, +/- 1 pad |
|
|||
Leukocyte Esterase |
|
pos/neg, +/- 1 pad |
|||||
|
Nitrite |
|
pos/neg, +/- 1 pad |
|
|||
|
pH, Urine |
|
pos/neg, +/- 1 pad |
|
|||
|
Protein, Total, Urine |
|
pos/neg, +/- 1 pad |
|
|||
Specific Gravity, Urine |
|
0.01 |
|||||
|
Urine Sediment (Microscopic ID) |
|
correct/incorrect |
|
|||
|
Urobilinogen |
|
pos/neg, +/- 1 pad |
|
|||
|
|
|
|||||
|
NR |
Glucose, Whole Blood |
|
6 mg/dL |
20 |
||
|
|
|
|
||||
|
NR |
Glucose, Whole Blood |
|
6 mg/dL |
10 |
||
|
|
|
|
||||
|
|
|
|
||||
|
|
|
|
||||
|
Fern(ing) Test |
|
present/absent |
|
|||
|
KOH Skin Preparation |
|
pos/neg |
|
|||
|
Nasal Eosinophils |
|
pos/neg |
|
|||
|
Pinworm Preparation |
|
pos/neg |
|
|||
|
Sperm, Qualitative (Digital Image) |
|
pos/neg |
|
|||
|
Vaginal Wet Mount |
|
correct/incorrect |
|
|||
|
|
|
|||||
|
Fern(ing) Test |
|
present/absent |
|
|||
|
KOH Skin Preparation |
|
pos/neg |
|
|||
|
Nasal Eosinophils |
|
pos/neg |
|
|||
|
Pinworm Preparation |
|
pos/neg |
|
|||
|
Sperm, Qualitative (Digital Image) |
|
pos/neg |
|
|||
|
Urine Sediment |
|
correct/incorrect |
|
|||
|
Vaginal Wet Mount |
|
correct/incorrect |
|
|||
|
|
|
|
||||
|
|
|
|
||||
|
Activated Clotting Time |
|
|
20 |
|||
|
|
|
|||||
|
|
INR |
|
|
20 |
||
|
NR |
Prothrombin Time |
|
|
15 |
||
|
|
|
|
||||
CMS |
Activated Partial Thrombin Time (APTT) |
|
|
15 |
|||
CMS |
Fibrinogen |
|
|
20 |
|||
|
INR |
|
|
20 |
|||
|
INR Calculation |
|
0.2 percentage units |
|
|||
CMS |
Prothrombin Time |
|
|
15 |
|||
|
|
|
|
||||
|
|
|
|
||||
CMS |
Blood Cell Identification |
|
correct/incorrect |
|
|||
|
|
|
|
||||
|
NR |
Erythrocyte Sedimentation Rate (ESR) |
3SD |
|
|
||
|
|
|
|
||||
|
NR |
Erythrocyte Sedimentation Rate (ESR), Rapid |
3SD |
|
|
||
|
|
|
|
||||
CMS |
Erythrocyte (RBC) Count |
|
|
6 |
|||
CMS |
Hematocrit |
|
|
6 |
|||
CMS |
Hemoglobin |
|
|
7 |
|||
CMS |
Leukocyte (WBC) Count |
|
|
15 |
|||
CMS |
Leukocyte (WBC) Differential, Auto |
3SD |
|
|
|||
CMS |
Platelet Count |
|
|
25 |
|||
|
|
|
|||||
CMS |
Erythrocyte (RBC) Count |
|
|
6 |
|||
CMS |
Hematocrit |
|
|
6 |
|||
CMS |
Hemoglobin |
|
|
7 |
|||
CMS |
Leukocyte (WBC) Count |
|
|
15 |
|||
CMS |
Leukocyte (WBC) Differential, Auto |
3SD |
|
|
|||
CMS |
Platelet Count |
|
|
25 |
|||
|
|
|
|||||
CMS |
Erythrocyte (RBC) Count |
|
|
6 |
|||
CMS |
Hematocrit |
|
|
6 |
|||
CMS |
Hemoglobin |
|
|
7 |
|||
CMS |
Leukocyte (WBC) Count |
|
|
15 |
|||
CMS |
Leukocyte (WBC) Differential, Auto |
3SD |
|
|
|||
CMS |
Platelet Count |
|
|
25 |
|||
|
|
|
|||||
CMS |
Erythrocyte (RBC) Count |
|
|
6 |
|||
CMS |
Hematocrit |
|
|
6 |
|||
CMS |
Hemoglobin |
|
|
7 |
|||
CMS |
Leukocyte (WBC) Count |
|
|
15 |
|||
CMS |
Leukocyte (WBC) Differential, Auto |
3SD |
|
|
|||
CMS |
Platelet Count |
|
|
25 |
|||
|
|
|
|||||
CMS |
Erythrocyte (RBC) Count |
|
|
6 |
|||
CMS |
Hematocrit |
|
|
6 |
|||
CMS |
Hemoglobin |
|
|
7 |
|||
CMS |
Leukocyte (WBC) Count |
|
|
15 |
|||
CMS |
Leukocyte (WBC) Differential, Auto |
3SD |
|
|
|||
CMS |
Platelet Count |
|
|
25 |
|||
|
|
|
|
||||
CMS |
Erythrocyte (RBC) Count |
|
|
6 |
|||
CMS |
Hematocrit |
|
|
6 |
|||
CMS |
Hemoglobin |
|
|
7 |
|||
CMS |
Leukocyte (WBC) Count |
|
|
15 |
|||
CMS |
Leukocyte (WBC) Differential, Auto |
3SD |
|
|
|||
CMS |
Platelet Count |
|
|
25 |
|||
|
|
|
|||||
CMS |
Hematocrit |
|
|
6 |
|||
CMS |
Hemoglobin |
|
|
7 |
|||
|
|
|
|||||
|
Hematocrit |
|
|
6 |
|||
|
Hemoglobin |
|
|
7 |
|||
|
|
|
|||||
|
Reticulocytes, Automated |
|
0.5 |
30 |
|||
|
Reticulocytes, Manual |
|
2.5 |
30 |
|||
|
|
|
|||||
|
Sickle Cell Screen |
|
pos/neg |
|
|||
|
|
|
|||||
|
NR |
Eosinophils, Urine |
|
present/absent |
|
||
|
|||||||
|
|
|
|
||||
CMS |
D (Rh) Typing |
|
pos/neg |
|
|||
|
|
|
|||||
|
Direct Antiglobulin |
|
pos/neg |
|
|||
|
|
|
|||||
CMS |
ABO Typing |
|
correct/incorrect grouping |
|
|||
CMS |
D (Rh) Typing |
|
pos/neg |
|
|||
|
|
|
|||||
CMS |
ABO Typing |
|
correct/incorrect grouping |
|
|||
CMS |
Compatibility Testing (Crossmatch) |
|
compatible/incompatible |
|
|||
CMS |
D (Rh) Typing |
|
pos/neg |
|
|||
CMS |
Unexpected Antibody Detection |
|
detected/ undetected |
|
|||
CMS |
Unexpected Antibody Identification |
|
correct/incorrect |
|
|||
|
|
|
|
||||
CMS |
ABO Typing |
|
correct/incorrect grouping |
|
|||
CMS |
Compatibility Testing (Crossmatch) |
|
compatible/incompatible |
|
|||
CMS |
D (Rh) Typing |
|
pos/neg |
|
|||
CMS |
RBC Antigen Typing |
|
correct/incorrect |
|
|||
CMS |
Unexpected Antibody Detection |
|
detected/ undetected |
|
|||
CMS |
Unexpected Antibody Identification |
|
correct/incorrect |
|
|||
|
|
||||||
|
|
||||||
CMS |
Antinuclear Antibody (ANA) Screen |
|
pos/neg |
|
|||
Anti-dsDNA |
pos/neg |
||||||
Anti-ssDNA |
pos/neg |
||||||
Anti-RNP |
pos/neg |
||||||
Anti-Sm |
pos/neg |
||||||
Anti-RNP/Sm |
pos/neg |
||||||
Anti-SSA |
pos/neg |
||||||
Anti-SSB |
pos/neg |
||||||
Anti-SSA/SSB |
pos/neg |
||||||
Florescence Pattern |
correct/incorrect |
||||||
|
|
|
|
||||
CMS |
Antistreptolysin O (ASO) |
|
pos/neg |
|
|||
|
|
|
|||||
|
C-Reactive Protein (CRP), Qualitative |
|
pos/neg |
|
|||
|
C-Reactive Protein (CRP), Quantitative |
3SD |
0.4 mg/dL |
|
|||
******* |
|||||||
SARS CoV-2 Antibody |
pos/neg |
||||||
|
|
|
|||||
CMS |
Antistreptolysin O (ASO) |
|
pos/neg |
|
|||
|
C-Reactive Protein (CRP), Qualitative |
|
pos/neg |
|
|||
|
C-Reactive Protein (CRP), Quantitative |
3SD |
0.4 mg/dL |
|
|||
CMS |
Infectious Mononucleosis |
|
pos/neg |
|
|||
CMS |
Rheumatoid Factor (RF), Qualitative |
|
pos/neg |
|
|||
CMS |
Rheumatoid Factor (RF), Quantitative, titer |
|
+/- 2 dilution |
|
|||
|
Rheumatoid Factor (RF), Quantitative, u/mL |
|
2 U/L |
30 |
|||
|
|
|
|||||
|
Helicobacter Pylori Antibody |
|
pos/neg |
|
|||
|
|
|
|||||
Hepatitis, Anti-HAV, IgM |
|
pos/neg |
|
||||
Hepatitis, Anti-HAV, Total |
pos/neg |
||||||
CMS |
Hepatitis, Anti-HBc, IgM |
|
pos/neg |
|
|||
CMS |
Hepatitis, Anti-HBc, Total |
|
pos/neg |
|
|||
|
Hepatitis, Anti-HBs |
|
pos/neg |
|
|||
|
Hepatitis, Anti-HCV |
|
pos/neg |
|
|||
CMS |
Hepatitis, HBeAg |
|
pos/neg |
|
|||
CMS |
Hepatitis, HBsAg |
|
pos/neg |
|
|||
|
|
|
|
||||
CMS |
|
HIV, Oral Fluids (confirmation) |
|
pos/neg |
|
||
CMS |
HIV, Oral Fluids (screening) |
|
pos/neg |
|
|||
|
|
|
|||||
|
HIV, Waived |
|
pos/neg |
|
|||
|
HIV, p24 Antigen |
|
pos/neg |
|
|||
|
|
|
|||||
CMS |
HIV, Anti-HIV 1 (confirmation) |
|
pos/neg |
|
|||
CMS |
HIV, Anti-HIV 1 or 1/2 (screening) |
|
pos/neg |
|
|||
|
HIV, p24 Antigen |
|
pos/neg |
|
|||
|
|
|
|||||
CMS |
Complement C3 |
3SD |
|
|
|||
CMS |
Complement C4 |
3SD |
|
|
|||
CMS |
IgA |
3SD |
|
|
|||
CMS |
IgE |
3SD |
|
|
|||
CMS |
IgG |
|
|
25 |
|||
CMS |
IgM |
3SD |
|
|
|||
|
|
|
|
||||
|
NR |
Lyme Disease |
|
pos/neg |
|
||
|
|
|
|
||||
CMS |
Infectious Mononucleosis |
|
pos/neg |
|
|||
|
|
|
|||||
|
Infectious Mononucleosis |
|
pos/neg |
|
|||
Mycoplasma Antibody |
pos/neg |
||||||
|
|
|
|
||||
CMS |
Rheumatoid Factor (RF), Qualitative |
|
pos/neg |
|
|||
CMS |
|
Rheumatoid Factor (RF), Quantitative, titer |
|
+/- 2 dilution |
|
||
|
|
Rheumatoid Factor (RF), Quantitative, u/mL |
|
2 U/L |
30 |
||
|
|
|
|
||||
CMS |
Rubella, IgG |
|
pos/neg |
|
|||
|
|
|
|||||
CMS |
Syphilis, Qualitative |
|
pos/neg |
|
|||
CMS |
Syphilis, Quantitative |
|
+/- 1 dil |
|
|||
|
|
|
|
||||
|
|
Cytomegalovirus, IgG |
|
pos/neg |
|
||
|
|
Cytomegalovirus, IgM |
|
pos/neg |
|
||
|
|
Herpes Simplex Virus, Type I, IgG |
|
pos/neg |
|
||
|
|
Herpes Simplex Virus, Type I, IgM |
|
pos/neg |
|
||
|
|
Herpes Simplex Virus, Type I/II, IgG |
|
pos/neg |
|
||
|
|
Herpes Simplex Virus, Type I/II, IgM |
|
pos/neg |
|
||
|
|
Rubella, IgM |
|
pos/neg |
|
||
|
|
Toxoplasma, IgG |
|
pos/neg |
|
||
|
|
Toxoplasmosis, IgM |
|
pos/neg |
|
||
|
|||||||
|
|
|
|
||||
CMS |
Acid-Fast Bacteria/Smears |
|
pos/neg |
|
|||
|
|
|
|||||
CMS |
Antimicrobial Susceptibility |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Stool Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Blood Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, CSF Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Genital Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Throat Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Urine Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Wound Culture |
|
correct/incorrect |
|
|||
|
|
||||||
CMS |
Antimicrobial Susceptibility |
|
correct/incorrect |
|
|||
|
Colony Count, Urine |
|
growth/ no growth |
|
|||
CMS |
Gram Stain Identification |
|
pos/neg |
|
|||
|
Gram Stain Organism Morphology |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Stool Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Blood Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, CSF Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Genital Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Throat Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Urine Culture |
correct/incorrect |
|||||
CMS |
Organism Identification, Wound Culture |
|
correct/incorrect |
||||
|
Strep Group A, Ag Screen, Supplemental |
|
pos/neg |
|
|||
|
|
|
|
||||
|
|
Organism Identification, Blood Culture |
|
correct/incorrect |
|
||
|
|
|
|
||||
CMS |
C Difficile Toxin A Antigen Detection |
|
pos/neg |
|
|||
CMS |
C Difficile Toxin B Antigen Detection |
|
pos/neg |
|
|||
Campylobacter |
correct/incorrect |
||||||
|
|
|
|||||
CMS |
Chlamydia Antigen Screen |
|
pos/neg |
|
|||
CMS |
GC, Antigen Screen |
|
pos/neg |
|
|||
CMS |
Strep Group B, Antigen Screen |
|
pos/neg |
|
|||
|
|
|
|||||
|
Colony Count, Urine |
|
correct/incorrect |
|
|||
******* |
|||||||
SARS-CoV-2 Antigen |
|||||||
******* |
|||||||
SARS CoV-2 Detection, Molecular |
|||||||
|
|
|
|||||
CMS |
Organism Identification, Genital Culture |
|
correct/incorrect |
|
|||
|
|
|
|
||||
CMS |
Gram Stain Identification |
|
pos/neg |
|
|||
|
Gram Stain Organism Morphology |
|
correct/incorrect |
|
|||
|
|
|
|||||
|
MRSA |
|
pos/neg |
|
|||
|
|
|
|||||
|
Rotavirus Antigen Screen |
|
pos/neg |
|
|||
|
|
|
|||||
CMS |
Rotavirus Antigen Screen |
|
pos/neg |
|
|||
|
|
|
|||||
|
Shiga Toxin |
|
pos/neg |
|
|||
|
|
|
|||||
CMS |
Strep Group A, Antigen Screen |
|
pos/neg |
|
|||
pos/neg |
|||||||
CMS |
Strep Group A Antigen Screen |
pos/neg |
|||||
|
|
|
|||||
|
Strep Group A, Antigen Screen |
|
pos/neg |
|
|||
|
|
|
|||||
CMS |
Organism Identification, Throat Culture |
|
correct/incorrect |
|
|||
|
|
|
|||||
CMS |
Antimicrobial Susceptibility |
|
correct/incorrect |
|
|||
|
Colony Count, Urine |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Throat Culture |
|
correct/incorrect |
|
|||
CMS |
Organism Identification, Urine Culture |
|
correct/incorrect |
|
|||
|
|
|
|||||
CMS |
Antimicrobial Susceptibility |
|
correct/incorrect |
|
|||
Colony Count, Urine |
correct/incorrect |
||||||
CMS |
Organism Identification, Urine Culture |
|
correct/incorrect |
|
|||
|
|
|
|||||
Urease |
pos/neg |
||||||
|
|
||||||
|
Candida |
|
pos/neg |
|
|||
CMS |
Gardnerella |
|
pos/neg |
|
|||
|
Trichomonas |
|
pos/neg |
|
|||
|
|
|
|||||
CMS |
Adenovirus Antigen Screen |
|
pos/neg |
|
|||
CMS |
Influenza, Type A. Antigen Screen |
|
pos/neg |
|
|||
CMS |
Influenza, Type B, Antigen Screen |
|
pos/neg |
|
|||
CMS |
Respiratory Syncytial Virus (RSV) Antigen |
|
pos/neg |
|
|||
|
|
|
|
||||
|
|
Adenovirus Antigen Screen, Waived |
|
pos/neg |
|
||
|
Influenza, Type A, Antigen Screen, Waived |
|
pos/neg |
|
|||
|
Influenza, Type B, Antigen Screen, Waived |
|
pos/neg |
|
|||
|
|
Respiratory Syncytial Virus (RSV) Antigen, Wv |
|
pos/neg |
|
||
|
|
|
|
||||
|
|
|
|
||||
|
|
KOH Preparation |
|
correct/incorrect |
|
||
CMS |
Cryptosporidium Immunoassay |
|
pos/neg |
|
|||
CMS |
Giardia Immunoassay |
pos/neg |
|||||
|
|
|
|||||
CMS |
Parasitology |
|
correct/incorrect |
|
|||
|
|
||||||
|
|
||||||
|
CAP |
Antisperm Antibody |
|
pos/neg |
|
||
|
|
|
|
||||
|
NR |
Embryo Grading |
|
correct/incorrect |
|
||
|
|
|
|
||||
|
CAP |
Fetal Fibronectin (fFN) |
|
pos/neg |
|
||
|
|
|
|
||||
|
NR |
Fetal Membrane Rupture (PAMG-1) |
|
pos/neg |
|
||
|
|
|
|
||||
|
NR |
IVF, Human Sperm Cell Survivial, Media Acceptability |
|
acceptable (yes/no) |
|
||
|
NR |
IVF, Mouse Embryo, Media Acceptability |
|
acceptable (yes/no) |
|
||
Sex Status |
correct/incorrect |
||||||
Euploid or Anuploid Status |
correct/incorrect |
||||||
Chromosome addition or deletion |
correct/incorrect |
||||||
|
|
|
|
||||
|
Sperm Count, Qualitative (Post Vasectomy) |
|
pos/neg |
|
|||
|
CAP |
Sperm Count, Quantitative |
|
7 million/mL |
30 |
||
CAP |
Sperm Count Qual-Post Vasectomy |
pos/neg |
|||||
|
|
|
|
||||
|
NR |
Sperm Morphology, % |
3SD |
5 percentage units |
|
||
|
NR |
Sperm Morphology, Cell ID |
|
correct/incorrect |
|
||
|
|
|
|
||||
|
NR |
Sperm Motility |
|
12 percentage units |
25 |
||
|
NR |
Sperm Motility, Forward Progression % |
|
12 percentage units |
25 |
||
|
NR |
Sperm Motility, Frwrd Progression, semi-qnt. |
|
correct/incorrect |
|
||
|
|
|
|
||||
|
CAP |
Sperm Viability |
|
10 percentage units |
20 |
||
|
|
|
|
|
|||
|
|
|
|
||||
|
Glucose, Whole Blood |
|
6 mg/dL |
20 |
|||